Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration
US 8,927,483 Lapsed on the fee recordLapsed Jan 6, 2019 on the fee record · From the USPTO record
20-year base term ended Sep 1, 2026
First maintenance fee unpaid; grace period ended.
Sep 1, 2006
Jan 6, 2019
Jan 6, 2015
Oct 28, 2028
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 1, 2006, when the earliest non-provisional application in its chain was filed (this one was filed Jan 26, 2009) | Sep 1, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +788 days, USPTO patent term adjustment record | Oct 28, 2028 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | lapsed Jan 6, 2019 | High confidence |
| Computed term end | The steps above, in order | Jan 6, 2019 | From the USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.